The Voice of Addiction Medicine

Advocacy

Federal and State Advocacy Toolkits

Federal Advocacy Toolkit

Sample Letter to Congress
How Do I Call Congress and What Do I Say?
Reaching out to the Media, an advocacy resource provided by Faces and Voices of Recovery
Sample Op-Ed
Improving the Quality of Health Care for Mental and Substance-Use Conditions, a 2005 Institute of Medicine report.
Parity Toolkit for Addiction & Mental Health Consumers, Providers & Advocates
US Department of Labor FAQ's: Understanding Implementation of Mental Health Parity and Addiction Equity Act

State Advocacy Toolkit

How to Contact your State Legislators
Sample Letter to Governor
Sample Local Op-Ed
Blueprint for the States

Evidence Supporting Access to Opioid Addiction Treatment Pharmacotherapies

ASAM Consensus Statement on Buprenorphine
Societal Costs of Prescription Opioid Abuse in the US
Review of the Economic Burden of Prescription Opioid Abuse

ASAM Letters and Comments

National Institute on Drug Abuse (NIDA), Regarding Dissemination and Implementation Research Priorities. March 30, 2013.

Food and Drug Administration, Regarding New Drug Application 204442, PROBUPHINE. March 13, 2013

Department of Health and Human Services, Regarding Essential Health Benefits for Medicaid Alternative Benefit Plans. February 21, 2013.

Drug Enforcement Agency, Regarding the Proposed Rule for Disposal of Controlled Substances. February 19, 2013.

United States Preventive Services Task Force, Regarding the Draft Research Plan for Reviewing Interventions to Reduce Nonmedical Use of Drugs in Children and Adolescents. February 11, 2013.

Office of the National Coordinator for Health Information Technology, Regarding the Stage 3 Definition of Meaningful Use of Electronic Health Records (EHRs). January 14, 2013.

Department of Health and Human Services, Regarding the Proposed Rule for Essential Health Benefits. December 24, 2012.

United States Preventive Services Task Force, Regarding Recommendations for Hepatitis C Virus (HCV) Screening. December 24, 2012.

Food and Drug Administration, Regarding the Drug Safety and Risk Management Meeting on Rescheduling Hydrocodone. November 6, 2012

Food and Drug Administration, Follow-up Letter to Relabeling Petition, Clarification of ASAM Position.  September 13, 2012

Food and Drug Administration, Multi-Specialty Petition Regarding Relabeling of Opioid Analgesics.  July 25, 2012

Food and Drug Administration, Regarding Advocacy for Naloxone Availability in an Attempt to Reduce Opioid-Related Deaths.  June 5, 2012

United States Senate, Regarding ASAM Support of S.2297, A Bill to Classify Any Substance Containing Hydrocodone a Schedule II Drug.  May 24, 2012

National Insitutes of Health, Recommendations for the Scientific Strategic Plan for the Proposed National Institute of Substance Use and Addiction Disorders (NISUAD).  May 11, 2012

Office of the National Coordinator for Health Information Technology, Regarding Proposed Standards, Implementation Specifications and Certification Criteria for Electronic Health Record (EHR) Technology.  May 7, 2012

Centers for Medicare and Medicaid Services, Regarding Proposed Rules for Implementing Stage 2 of the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs.  May 7, 2012

Centers for Medicare and Medicaid Services, Exclusion of Existing or Future Reformulated Products Incorporating Abuse Deterrent Technology from the Additional Rebate Formulate under the Affordable Care Act.  April 2, 2012

TRICARE, Removal of the Prohibition to Use Addictive Drugs in the Maintenance Treatment of Substance Dependence in TRICARE Beneficiaries.  February 21, 2012

Useful Websites

THOMAS, Legislative information from the Library of Congress.
U.S. House of Representatives
U.S. Senate
SAMHSA, Substance Abuse and Mental Health Services Administration
ONDCP, Office of National Drug Control Policy
NIDA, National Institute on Drug Abuse
NIAAA, National Institute on Alcohol Abuse and Alcoholism
NIMH, National Institute of Mental Health
National Conference of State Legislatures
National Association of Insurance Commissioners
Legal Action Center
Faces and Voices of Recovery
Ensuring Solutions to Alcohol Problems, Provides research-based information on effective alcohol treatment.
Join Together, Resource for alcohol and drug policy, prevention and treatment.
 

HealthCare.gov badge

Health Care Reform

Health Care Reform (HCR) Law
How Does HCR Support Addiction Treatment?
HCR Resources: Information, Updates, Webinars
What's Happening in Your State?

Find a Physician

Our nationwide directory of addiction medicine professionals.

Find a Physician Near You »

Join ASAM Today!

© 2013 American Society of Addiction Medicine. All rights reserved.

4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815
Phone: 301-656-3920 | Fax: 301-656-3815 | email@asam.org

Association Web Design by Matrix Group International, Inc.